High-profile patient safety issues have put companies under increasing pressure to identify potential safety problems before they become a threat to public health. The level of scrutiny – by regulatory authorities, health care professionals, government officials, the media and patients – is on the rise. Now more than ever, there’s a need for greater pharmacovigilance in pre-approval drug development, as well as post-marketing safety surveillance processes.
This demo explores how SAS Visual Analytics can help you rapidly uncover key medical insights across growing volumes of real-world data.
View the Interactive Report
Get Full Access to SAS® Visual Analytics